We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Shire Pharmaceuticals Ireland Limited

5 Riverwalk, Citywest Business Campus, Dublin 24, Ireland,
Telephone: +353 1 429 7700
Fax: +353 1 429 7701
Medical Information Direct Line: 1 800 818 016
Medical Information e-mail: medinfoemea@shire.com
Customer Care direct line: +44 (0)1256 894 107
Patient Information Leaflet last updated on medicines.ie: 27/09/2017
PIL Mezavant XL

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 27/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
  • Change to MA holder contact details
Updated on 19/04/2017 and displayed until 27/09/2017
Reasons for adding or updating:
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
Updated on 24/03/2016 and displayed until 19/04/2017
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/08/2014 and displayed until 24/03/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Addition of information on reporting a side effect.
Updated on 15/02/2012 and displayed until 22/08/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to further information section
Updated on 08/10/2010 and displayed until 15/02/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 01/04/2008 and displayed until 08/10/2010
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Mesalazine